Evidence map›Paper›PMID 24809698›Full record

ArticlePLoS genetics2014

A dominant-negative mutation of mouse Lmx1b causes glaucoma and is semi-lethal via LDB1-mediated dimerization [corrected].

Sally H Cross, Danilo G Macalinao, Lisa McKie, Lorraine Rose, Alison L Kearney, Joe Rainger, Caroline Thaung, Margaret Keighren, Shalini Jadeja, Katrine West and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Neuroinflammation in glaucoma: a myriad of cellular pathways and players.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Proliferative retinopathy in nail-patella syndrome.American journal of ophthalmology case reports · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. MicroRNAs in the aqueous humor of patients with different types of glaucoma.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Sally H CrossMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom.
Danilo G MacalinaoThe Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Lisa McKieMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom.
Lorraine RoseCentre for Genomic and Experimental Medicine, IGMM, Edinburgh, United Kingdom.
Alison L KearneyThe Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Joe RaingerMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom.
Caroline ThaungUCL Institute of Ophthalmology, London, United Kingdom.
Margaret KeighrenMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom.
Shalini JadejaMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom.
Katrine WestMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom.
Stephen C KneelandThe Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Richard S SmithThe Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Gareth R HowellThe Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Fiona YoungElectron Microscopy, Pathology, Western General Hospital, Edinburgh, United Kingdom.
Morag RobertsonMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom.
Rob van T' HofCentre for Genomic and Experimental Medicine, IGMM, Edinburgh, United Kingdom.
Simon W M JohnThe Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Ian J JacksonMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom; The Roslin Institute, University of Edinburgh, Easter Bush, United Kingdom.
University of Edinburgh · GBJackson Laboratory · USEdinburgh Cancer Research · GBHoward Hughes Medical Institute · USMRC Institute of Genetics and Molecular Medicine · GBRoslin Institute · GBUniversity College London · GBWestern General Hospital · GB

Funding

Factors Determining Intraocular Pressure and Glaucoma SusceptibilityR01EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 2002 to 2018
$12.4M
FACTORS DETERMINING INTRAOCULAR PRESSURER29EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 1997 to 2001
$227k
Howard Hughes Medical InstituteMedical Research Council MC_PC_U127561112Medical Research Council MC_U127561112NEI NIH HHS EY11721NEI NIH HHS R01 EY011721NEI NIH HHS R29 EY011721
6 · The paper itself

Abstract

Mutations in the LIM-homeodomain transcription factor LMX1B cause nail-patella syndrome, an autosomal dominant pleiotrophic human disorder in which nail, patella and elbow dysplasia is associated with other skeletal abnormalities and variably nephropathy and glaucoma. It is thought to be a haploinsufficient disorder. Studies in the mouse have shown that during development Lmx1b controls limb dorsal-ventral patterning and is also required for kidney and eye development, midbrain-hindbrain boundary establishment and the specification of specific neuronal subtypes. Mice completely deficient for Lmx1b die at birth. In contrast to the situation in humans, heterozygous null mice do not have a mutant phenotype. Here we report a novel mouse mutant Icst, an N-ethyl-N-nitrosourea-induced missense substitution, V265D, in the homeodomain of LMX1B that abolishes DNA binding and thereby the ability to transactivate other genes. Although the homozygous phenotypic consequences of Icst and the null allele of Lmx1b are the same, heterozygous Icst elicits a phenotype whilst the null allele does not. Heterozygous Icst causes glaucomatous eye defects and is semi-lethal, probably due to kidney failure. We show that the null phenotype is rescued more effectively by an Lmx1b transgene than is Icst. Co-immunoprecipitation experiments show that both wild-type and Icst LMX1B are found in complexes with LIM domain binding protein 1 (LDB1), resulting in lower levels of functional LMX1B in Icst heterozygotes than null heterozygotes. We conclude that Icst is a dominant-negative allele of Lmx1b. These findings indicate a reassessment of whether nail-patella syndrome is always haploinsufficient. Furthermore, Icst is a rare example of a model of human glaucoma caused by mutation of the same gene in humans and mice.

Indexed as

Genes, DominantGenes, LethalAllelesAnimalsBody PatterningDimerizationGlaucomaHeterozygoteLIM-Homeodomain ProteinsMiceMice, TransgenicMutation, MissenseTranscription FactorsLIM homeobox transcription factor 1 betaLIM-Homeodomain ProteinsTranscription Factors

Identifiers

PMID24809698
PMCPMC4014447
OpenAlexW1984335578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.